Sign in
Create a Profile
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Diseases and Conditions Researched
Alcoholism
What is the purpose of this trial?
The purpose of the study will be to evaluate the efficacy of mecamylamine in reducing alcohol consumption in smoking and non-smoking alcohol dependent patients.
We hypothesize that mecamylamine will result in a greater reduction of alcohol consumption than placebo. We further hypothesize that mecamylamine will be effective in reducing both alcohol consumption and smoking in a subset of alcoholics who also smoke.
Participation Guidelines
Gender: Both
Click here for detailed participation information for this trial.
| Sponsor: | Elizabeth Ralevski |
|---|---|
| Dates: | June 19, 2006 |
| Last Updated: | January 13, 2012 |
| Study HIC#: | 0402026364 |
| Clinicaltrials.gov ID: | NCT00342563 |
How will my information be used?
For more information about this trial, contact:
Melanie Russo
203-932-5711 ext 5667
melanie.russo@yale.edu
Principal Investigator
Petrakis, Ismene Leonida
Psychiatry
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
